Expertise in
9
conditions

Dr. Mark Kipnes

Endocrinology
Diabetes And Glandular Disease Clinic PA
5107 Medical Dr, 
San Antonio, TX 
Expertise in
9
conditions
Diabetes And Glandular Disease Clinic PA
5107 Medical Dr, 
San Antonio, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Kipnes is an Endocrinologist in San Antonio, Texas. Dr. Kipnes is highly rated in 9 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Diabetic Neuropathy.

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Diabetes and Glandular Disease Clinic PA
5107 Medical Dr, San Antonio, TX 78229
Call: 210-614-8612

Additional Areas of Focus

Dr. Kipnes has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Multi-center, Randomized, Parallel, Adaptive, Controlled Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control (CSII, MDI and SAP) at Home
Enrollment Status: Completed
Publish Date: August 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
Enrollment Status: Completed
Publish Date: June 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: LUM-201, rhGH Norditropin® pen
Study Phase: Phase 2
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
Prediabetes and Type 2 Diabetes Data Collection Study: T2Help
Prediabetes and Type 2 Diabetes Data Collection Study: T2Help
Enrollment Status: Unknown
Publish Date: October 05, 2021
Intervention Type: Device
Continuous Glucose Monitoring & Management In Type 2 Diabetes
Continuous Glucose Monitoring & Management In Type 2 Diabetes
Enrollment Status: Completed
Publish Date: March 22, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus
Enrollment Status: Active_not_recruiting
Publish Date: November 09, 2020
Intervention Type: Other, Biological
Study Drug: TOL-3021
Study Phase: Phase 2
A Single-Site, Investigator-Initiated Study to Evaluate Time in Range in Subjects With Type 2 Diabetes Mellitus Using Mealtime Inhaled Insulin (Afrezza®) Plus Basal Insulin Compared to Multiple Daily Injections
A Single-Site, Investigator-Initiated Study to Evaluate Time in Range in Subjects With Type 2 Diabetes Mellitus Using Mealtime Inhaled Insulin (Afrezza®) Plus Basal Insulin Compared to Multiple Daily Injections
Enrollment Status: Unknown
Publish Date: January 30, 2020
Intervention Type: Drug
Study Drug: Afrezza Inhalant Product
Study Phase: Phase 4
View 10 Less Clinical Trials

29 Total Publications

INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
Journal: Diabetes care
Published: August 13, 2025
View All 29 Publications
Similar Doctors
Expertise in
13
conditions
Dr. Ralph A. Defronzo
Endocrinology
Expertise in
13
conditions
Dr. Ralph A. Defronzo
Endocrinology
701 S Zarzamora St, 
San Antonio, TX 
 (7.1 miles away)
210-358-7500
Languages Spoken:
English
See accepted insurances

Ralph Defronzo is an Endocrinologist in San Antonio, Texas. Dr. Defronzo is highly rated in 13 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, Gastric Bypass, and Sleeve Gastrectomy.

Expertise in
4
conditions
Dr. Marzieh Salehi
Endocrinology
Expertise in
4
conditions
Dr. Marzieh Salehi
Endocrinology

University Of Texas Health Science Center San Antonio

7703 Floyd Curl Dr, 
San Antonio, TX 
 (0.7 miles away)
210-450-9050
Languages Spoken:
English
See accepted insurances

Marzieh Salehi is an Endocrinologist in San Antonio, Texas. Dr. Salehi is highly rated in 4 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Obesity, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy.

Expertise in
50
conditions
Dr. Shahid Aziz
Endocrinology
Expertise in
50
conditions
Dr. Shahid Aziz
Endocrinology

Office

10818 Town Center Dr Ste 101, 
San Antonio, TX 
 (6.4 miles away)
210-352-5006
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shahid Aziz is an Endocrinologist in San Antonio, Texas. Dr. Aziz is highly rated in 50 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Hypothyroidism, Obesity in Children, and Type 1 Diabetes (T1D).

VIEW MORE Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kipnes's expertise for a condition
ConditionClose
    • Distinguished
    • Type 2 Diabetes (T2D)
      Dr. Kipnes is
      Distinguished
      . Learn about Type 2 Diabetes (T2D).
      See more Type 2 Diabetes (T2D) experts
    • Advanced
    • Diabetic Neuropathy
      Dr. Kipnes is
      Advanced
      . Learn about Diabetic Neuropathy.
      See more Diabetic Neuropathy experts
    • Low Blood Sugar
      Dr. Kipnes is
      Advanced
      . Learn about Low Blood Sugar.
      See more Low Blood Sugar experts
    • Maturity Onset Diabetes of the Young
      Dr. Kipnes is
      Advanced
      . Learn about Maturity Onset Diabetes of the Young.
      See more Maturity Onset Diabetes of the Young experts
    • Obesity in Children
      Dr. Kipnes is
      Advanced
      . Learn about Obesity in Children.
      See more Obesity in Children experts
    • Osteoporosis
      Dr. Kipnes is
      Advanced
      . Learn about Osteoporosis.
      See more Osteoporosis experts
    • Postmenopausal Osteoporosis
      Dr. Kipnes is
      Advanced
      . Learn about Postmenopausal Osteoporosis.
      See more Postmenopausal Osteoporosis experts
    View All 8 Advanced Conditions
    • Experienced
    • Alopecia Areata
      Dr. Kipnes is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Autosomal Recessive Hypotrichosis
      Dr. Kipnes is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Diabetic Ketoacidosis
      Dr. Kipnes is
      Experienced
      . Learn about Diabetic Ketoacidosis.
      See more Diabetic Ketoacidosis experts
    • Familial Hypocalciuric Hypercalcemia Type 1
      Dr. Kipnes is
      Experienced
      . Learn about Familial Hypocalciuric Hypercalcemia Type 1.
      See more Familial Hypocalciuric Hypercalcemia Type 1 experts
    • Graves Disease
      Dr. Kipnes is
      Experienced
      . Learn about Graves Disease.
      See more Graves Disease experts
    • Growth Hormone Deficiency (GHD)
      Dr. Kipnes is
      Experienced
      . Learn about Growth Hormone Deficiency (GHD).
      See more Growth Hormone Deficiency (GHD) experts
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Endocrinologists San Antonio, TX
    3. Dr. Mark Kipnes
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.